Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.
Spica Therapeutics has raised $11.4M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Spica Therapeutics's investors include Qbic Fund, Bioqube Ventures, PMV.
Spica Therapeutics is headquartered in Antwerp, Belgium.
Spica Therapeutics is a biotech company to transform macrophage biology into breakthrough therapies for patients.
Spica Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spica Therapeutics — Funding & Investors." VCBacked, June 4, 2025, https://www.vcbacked.co/company/spica-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Spica Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/spica-therapeutics
{{cite web |title=Spica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spica-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated